Colgate-Palmolive Company (CL)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $79.23B
Last updated: Nov 17, 2026 at 11:05 AM ET
Colgate-Palmolive Company (CL) Stock Forecast
Analysts expect Colgate-Palmolive Company (CL) to earn $3.92 per share in the fiscal year ending Dec 31, 2026, on revenue of $21.39B. Of 21 analysts, 13 rate the stock Buy or Strong Buy, 7 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 5 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 21 ratings average 2.19, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 62% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 6 | 28.6% |
| Buy | 7 | 33.3% |
| Hold | 7 | 33.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 4.8% |
- Consensus
- Buy
- Total analysts
- 21
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 4.6% and revenue estimates rise 2.3%.
- Fiscal year ending Dec 31, 2026
- $3.92
- EPS consensus, revenue $21.39B
- Fiscal year ending Dec 31, 2027
- $4.10
- EPS consensus, revenue $21.89B
- Next report
- Jan 28, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $3.92 | $3.85 to $4.02 | 20 | $21.39B | $21.03B to $21.47B | 18 |
| Dec 31, 2027 | $4.10 | $3.97 to $4.25 | 20 | $21.89B | $21.55B to $22.08B | 18 |
Quarterly Estimates
The EPS consensus falls from $1.01 for the quarter ending Dec 31, 2026 to $0.97 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.01 | $0.94 to $1.07 | 21 | $5.54B | $5.22B to $5.72B | 18 |
| Mar 31, 2027 | $0.97 | $0.89 to $1.02 | 13 | $5.44B | $5.35B to $5.48B | 9 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 5 upward and 18 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 3 | 5 |
| Fiscal year ending Dec 31, 2027 | 2 | 8 |
| Quarter ending Mar 31, 2027 | 0 | 5 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 1.0% from $3.88.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $3.92 | $3.92 | $3.87 | $3.88 | $3.88 | +1.2% |
| Fiscal year ending Dec 31, 2027 | $4.10 | $4.10 | $4.10 | $4.11 | $4.10 | 0.0% |
| Quarter ending Mar 31, 2027 | $0.97 | $0.98 | $0.99 | $0.99 | $0.99 | -2.0% |
Frequently Asked Questions About CL
What is the CL stock forecast?
Consensus analyst estimates put Colgate-Palmolive Company's EPS at $3.92 for the fiscal year ending Dec 31, 2026, on revenue of $21.39B. The consensus rating from 21 analysts is Buy.
How do analysts rate CL stock?
Of 21 analysts covering Colgate-Palmolive Company, 6 rate it Strong Buy, 7 Buy, 7 Hold, 0 Sell and 1 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from CL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $3.92, with estimates from $3.85 to $4.02 from 20 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.10, with estimates from $3.97 to $4.25 from 20 analysts.
What revenue do analysts expect from Colgate-Palmolive Company next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $21.39B, with estimates from $21.03B to $21.47B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $21.89B, with estimates from $21.55B to $22.08B.
How many analysts cover CL?
21 analysts rate Colgate-Palmolive Company stock, and 20 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors